[1] |
WANG Y, MA D, WU Z, et al. Clinical application of mesenchymal stem cells in rheumatic diseases[J]. Stem Cell Res Ther, 2021, 12(1):567. doi: 10.1186/s13287-021-02635-9.
|
[2] |
CHEN L, QU J, KALYANI F S, et al. Mesenchymal stem cell-based treatments for COVID-19:status and future perspectives for clinical applications[J]. Cell Mol Life Sci, 2022, 79(3):142. doi: 10.1007/s00018-021-04096-y.
|
[3] |
ALONSO-GOULART V, CARVALHO L N, MARINHO A L G, et al. Biomaterials and adipose-derived mesenchymal stem cells for regenerative medicine:A systematic review[J]. Materials(Basel), 2021, 14(16):4641. doi: 10.3390/ma14164641.
|
[4] |
PARK J S, PARK G, HONG H S. Age affects the paracrine activity and differentiation potential of human adipose-derived stem cells[J]. Mol Med Rep, 2021, 23(2):160. doi: 10.3892/mmr.2020.11799.
|
[5] |
黄志伟, 刘涛, 陈晓波, 等. OX40Ig修饰大鼠脂肪间充质干细胞的实验研究[J]. 天津医药, 2021, 49(10):1009-1013.
|
|
HUANG Z W, LIU T, CHEN X B, et al. Experimental study on OX40Ig modified rat adipose derived mesenchymal stromal cells[J]. Tianjin Med J, 2021, 49(10):1009-1013. doi: 10.11958/20203592.
|
[6] |
耿洁, 刘涛, 姜锦, 等. 真核表达载体介导的ICOSIg基因在大鼠脂肪间充质干细胞中表达的实验研究[J]. 天津医药, 2020, 48(8):711-714.
|
|
GENG J, LIU T, JIANG J, et al. The expression ICOSIg gene mediated by eukaryotic expression vector in rat adipose tissue-derived mesenchymal stem cells[J]. Tianjin Med J, 2020, 48(8):711-714. doi: 10.11958/20193697.
|
[7] |
HORINOUCHI C D, BARISÓN M J, ROBERT A W, et al. Influence of donor age on the differentiation and division capacity of human adipose-derived stem cells[J]. World J Stem Cells, 2020, 12(12):1640-1651. doi: 10.4252/wjsc.v12.i12.1640.
|
[8] |
JIN L, LU N, ZHANG W, et al. Altered properties of human adipose-derived mesenchymal stromal cell during continuous in vitro cultivation[J]. Cytotechnology, 2021, 73(4):657-667. doi: 10.1007/s10616-021-00486-z.
|
[9] |
KORNICKA K, MARYCZ K, TOMASZEWSKI K A, et al. The effect of age on osteogenic and adipogenic differentiation potential of human adipose derived stromal stem cells(hASCs) and the impact of stress factors in the course of the differentiation process[J]. Oxid Med Cell Longev, 2015, 2015:309169. doi: 10.1155/2015/309169.
|
[10] |
PRALL W C, SALLER M M, SCHEUMAIER A, et al. Proliferative and osteogenic differentiation capacity of mesenchymal stromal cells:Influence of harvesting site and donor age[J]. Injury, 2018, 49(8):1504-1512. doi: 10.1016/j.injury.2018.06.024.
|
[11] |
CHEN X, WANG F, HUANG Z, et al. Clinical applications of mesenchymal stromal cell-based therapies for pulmonary diseases:An update and concise review[J]. Int J Med Sci, 2021, 18(13):2849-2870. doi: 10.7150/ijms.59218.
|
[12] |
王玉亮, 王峰, 耿洁. 细胞因子与细胞因子风暴[J]. 天津医药, 2020, 48(6):494-499.
|
|
WANG Y L, WANG F, GENG J. Cytokine and cytokine storm[J]. Tianjin Med J, 2020, 48(6):494-499. doi: 10.11958/20200323.
|
[13] |
王平, 顾昕, 张娜, 等. 干扰素γ增强脂肪间充质干细胞对淋巴细胞的免疫调节作用[J]. 天津医药, 2016, 44(6):683-686.
|
|
WANG P, GU X, ZHANG N, et al. Interferon-γ promotes immunomodulatory of adipose tissue-derived mesenchymal stem cells on peripheral blood lymphocytes[J]. Tianjin Med J, 2016, 44(6):683-686. doi: 10.11958/20150261.
|